Lancet Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 10

  • Portfolio
  • 1

  • Exits
  • 5

Exits

Lancet Capital General Information

Company Description

Founded in 1998, Lancet Capital is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics, and diagnostic systems.

Business Details

Year Founded
1998
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Corporate Office
  • 52 Richwood Street
  • Boston, MA 02132
  • United States
+1 (412) 000-0000

Lancet Capital Investments (10)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Noveome Biotherapeutics 01-Aug-2023 Later Stage VC 000.00 Biotechnology Clinical Trials - Phase 2
Noveome Biotherapeutics 01-Sep-2021 00000 00000 Biotechnology Clinical Trials - Phase 2
Biodel 02-Aug-2006 00000 00000 0000 Pharmaceuticals Generating Revenue
Enanta Pharmaceuticals 24-Jan-2004 00000 00000 000.00 Biotechnology Generating Revenue/Not Profitable
Dyax 14-Mar-2003 0000 00.000 Discovery Tools (Healthcare) Generating Revenue
Scion Pharmaceuticals 29-Jul-2002 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1
Stentor 19-Oct-2000 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue
Enanta Pharmaceuticals 28-Jul-2000 00000 00000 0000 Biotechnology Generating Revenue/Not Profitable
VivoQuest 01-Sep-1998 Seed Round Biotechnology Generating Revenue
Stentor Early Stage VC 000 Other Healthcare Technology Systems Generating Revenue
To view Lancet Capital’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lancet Capital Exits (5)

Company Name Exit Date Exit Type Exit Size
Dyax 22-Jan-2016 Merger/Acquisition 00.00
Enanta Pharmaceuticals 21-Mar-2013 000 0000
VivoQuest 20-Sep-2005 000000000000000000 00.00
Stentor 05-Aug-2005 Merger/Acquisition 00000
Scion Pharmaceuticals 17-Jun-2005 Merger/Acquisition
To view Lancet Capital’s complete exits history, request access »

Lancet Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lancet Capital Management, Team & Partners (2)

Name Title Deals Funds Boards Office
William Golden Co-Founder & Managing Director Boston, MA
You’re viewing 1 of 2 team members. Get the full list »

Lancet Capital Co-Investors (10)

Name With Exits Lead Partner Series Industry
Commonwealth of Pennsylvania 1 Series chart Industry bar
MAK Capital 0 0 Series chart Industry bar
Miraki Innovation 0 0 Series chart Industry bar
U.S. Department of Health and Human Services 0 Series chart Industry bar
University of Pittsburgh Endowment 0 Series chart Industry bar
You’re viewing 5 of 10 co-investors. Get the full list »

Lancet Capital FAQs

  • What is Lancet Capital?

    Founded in 1998, Lancet Capital is a venture capital firm based in Boston, Massachusetts.

  • When was Lancet Capital founded?

    Lancet Capital was founded in 1998.

  • Who is the founder of Lancet Capital?

    George Sing and William Golden are the founders of Lancet Capital.

  • Where is Lancet Capital headquartered?

    Lancet Capital is headquartered in Boston, MA.

  • How many investments has Lancet Capital made?

    Lancet Capital has made 10 investments.

  • What has Lancet Capital invested in?

    Lancet Capital has made numerous investments in companies like Noveome Biotherapeutics, Biodel, and Enanta Pharmaceuticals within the Biotechnology and Pharmaceuticals industries.

  • What has Lancet Capital invested in recently?

    Lancet Capital's latest investment was on 01-Aug-2023 in Noveome Biotherapeutics, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »